Quarterly report pursuant to Section 13 or 15(d)

Other current assets

v3.20.1
Other current assets
3 Months Ended
Mar. 31, 2020
Other current assets  
Other current assets

Note 8 — Other current assets

Other current assets consisted of the following (in thousands):

March 31, 

December 31, 

    

2020

    

2019

Corporate tax receivable

 

$

23,004

 

$

19,284

Prepayments

 

6,468

 

8,395

Clinical materials

 

952

 

1,459

Other current assets

 

908

 

1,809

$

31,332

$

30,947